Australian MND Treatment Enters Phase 2 Clinical Trial

An Australian-developed therapy for Motor Neurone Disease (MND) has progressed to a Phase 2 clinical trial. This treatment aims to halt disease progression and potentially restore function, offering new hope for patients with the debilitating neurological condition. The advancement marks a significant step in developing new therapeutic options.